D.C.J. van Dam

Faculty of Medical Sciences

Telephone:

+31 50 361 2401

E-mail:

d.c.j.van.dam umcg.nl

ORCID Research Portal

Publications

Comparison of size distribution and (Pro249-Ser258) epitope exposure in in vitro and in vivo derived Tau fibrils

Marreiro, A., Van Kolen, K., Sousa, C., Temmerman, L., Vasconcelos, B., Crespo-Rodriguez, R., van Weering, J. R. T., Van Dam, D. , De Deyn, P. P. , Apetri, A., Schoofs, L. & Mercken, M. H., 12-Nov-2020 , In : BMC Molecular and Cell Biology. 21 , 1 , p. 1-14 14 p. , 81.

Research output: Contribution to journal › Article › Academic › peer-review

Pentylenetetrazole-induced Seizure Susceptibility in the Tau58/4 Transgenic Mouse Model of Tauopathy

Van Erum, J., Valkenburg, F., Van Dam, D. & De Deyn, P. P. , 15-Jan-2020 , In : Neuroscience. 425 , p. 112-122 11 p.

Research output: Contribution to journal › Article › Academic › peer-review

Progressive tau aggregation does not alter functional brain network connectivity in seeded hTau.P301L mice

Detrez, J. R., Ben-Nejma, I. R. H., Van Kolen, K., Van Dam, D. , De Deyn, P. P. , Fransen, E., Verhoye, M., Timmermans, J-P., Nuydens, R., Van der Linden, A., Keliris, G. A. & De Vos, W. H., Sep-2020 , In : Neurobiology of Disease. 143 , 13 p. , 105011.

Research output: Contribution to journal › Article › Academic › peer-review

The Effect of Tryptophan 2,3-Dioxygenase Inhibition on Kynurenine Metabolism and Cognitive Function in the APP23 Mouse Model of Alzheimer's Disease

Sorgdrager, F. J. H., van Der Ley, C. P., van Faassen, M. , Calus, E., Nollen, E. A. , Kema, I. P. , van Dam, D. & De Deyn, P. P. , Dec-2020 , In : International journal of tryptophan research. 13 , 10 p. , 1178646920972657.

Research output: Contribution to journal › Article › Academic › peer-review

Alzheimer's disease: Neurotransmitters of the sleep-wake cycle

Van Erum, J., Van Dam, D. & De Deyn, P. P. , Oct-2019 , In : Neuroscience and Biobehavioral Reviews. 105 , p. 72-80 9 p.

Research output: Contribution to journal › Review article › Academic › peer-review

Alzheimer's disease and glaucoma: Look-alike neurodegenerative diseases

Wostyn, P., Van Dam, D. & De Deyn, P. P. , Apr-2019 , In : Alzheimers & dementia. 15 , 4 , p. 600-601 2 p.

Research output: Contribution to journal › Letter › Academic › peer-review

Evaluating the applicability of mouse SINEs as an alternative normalization approach for RT-qPCR in brain tissue of the APP23 model for Alzheimer's disease

Janssens, J., Crans, R. A. J., Van Craenenbroeck, K., Vandesompele, J., Stove, C. P., Van Dam, D. & De Deyn, P. P. , 15-May-2019 , In : Journal of Neuroscience Methods. 320 , p. 128-137 10 p.

Research output: Contribution to journal › Article › Academic › peer-review

Everolimus depletes plaque macrophages, abolishes intraplaque neovascularization and improves survival in mice with advanced atherosclerosis

Kurdi, A., Roth, L., Van der Veken, B., Van Dam, D. , De Deyn, P. P. , De Doncker, M., Neels, H., De Meyer, G. R. Y. & Martinet, W., Feb-2019 , In : Vascular pharmacology. 113 , p. 70-76 7 p.

Research output: Contribution to journal › Article › Academic › peer-review

How does a researcher choose the best rodent model for their Alzheimer's disease drug discovery study?

Van Dam, D. & De Deyn, P. P. , 8-Oct-2019 , In : Expert Opinion on Drug Discovery. 3 p.

Research output: Contribution to journal › Editorial › Academic › peer-review

Intrathecal cerebrospinal fluid infusion as a potential therapeutic strategy for Alzheimer's disease

Wostyn, P., Van Dam, D. & De Deyn, P. P. , Jan-2019 , In : Medical Hypotheses. 122 , p. 57 1 p.

Research output: Contribution to journal › Letter › Academic › peer-review

All (59) publications

View full research profile